Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-22

Clinical Trial Update: Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse [NA]

View source ↗

Summary

A feasibility study evaluating the use of trastuzumab subcutaneous during follow-up visits led by an Advanced Practice Nurse in breast cancer care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trastuzumab Subcutaneous (Trastuzumab)

Snippet

Sponsor: Institut de Cancérologie de la Loire | Conditions: Breast Neoplasms | NA | Status: UNKNOWN